On the other hand, TGF-β signaling is a potent inducer of growth arrest in cancer cells, and the GPI-anchored cell surface protein CD109 is a known negative regulator of TGF-β signaling by suppressing Smad2/3 phosphorylation and promoting degradation of the TGF-β receptor. Here, TGFB1 is linked to cancer.